Maeder Micha T, Münzer Thomas, Rickli Hans, Schoch Otto D, Korte Wolfgang, Hürny Christoph, Ammann Peter
Division of Cardiology, Department of Internal Medicine, Kantonsspital St. Gallen, CH-9007 St. Gallen, Switzerland.
Sleep Med. 2008 Oct;9(7):753-61. doi: 10.1016/j.sleep.2007.08.016. Epub 2007 Nov 5.
Obstructive sleep apnea syndrome (OSAS) is associated with autonomic dysfunction and metabolic abnormalities including obesity, dyslipidemia, and insulin resistance. Heart rate recovery at 1min after exercise termination (HRR-1) is a marker of vagal tone. We hypothesized that patients with more severe OSAS would have a lower HRR-1, either due to the co-existing metabolic abnormalities or OSAS.
Sixty-three patients with untreated OSAS (49.2+/-9.8years) without glucose- or lipid-lowering or negatively chronotropic drugs underwent cardiopulmonary exercise testing including HRR-1 measurement and assessment of several metabolic parameters. Patients with severe OSAS (apnea-hypopnea index [AHI]>30h(-1); n=32) were compared to patients with mild to moderate OSAS (AHI 5-30h(-1); n=31).
Patients with severe OSAS were more likely to be male (25 vs. 3%; p=0.01) and to have hypertension (72 vs. 39%; p=0.01); they also had higher fasting glucose (5.4+/-0.5 vs. 5.1+/-0.4mmol/l; p=0.016) and C-peptide [905 (651-1353) vs. 749 (597-919)pmol/l; p=0.028] levels compared to patients with mild to moderate OSAS. The groups did not differ with respect to peak heart rate (p=0.2) or peak oxygen consumption (p=0.9), but HRR-1 was significantly lower in patients with severe OSAS compared to patients with mild and moderate OSAS [20 (15-25) vs. 24 (18-34)bpm; p=0.022]. Higher AHI (p=0.01) and lower peak heart rate (p=0.02), but not body mass index or insulin resistance, were independently associated with lower HRR-1.
The severity of OSAS expressed as higher AHI is independently associated with lower HRR-1, a measure of autonomic dysfunction.
阻塞性睡眠呼吸暂停综合征(OSAS)与自主神经功能障碍以及包括肥胖、血脂异常和胰岛素抵抗在内的代谢异常有关。运动终止后1分钟时的心率恢复(HRR-1)是迷走神经张力的一个指标。我们推测,OSAS更严重的患者HRR-1会更低,这可能是由于并存的代谢异常或OSAS本身所致。
63例未接受治疗的OSAS患者(49.2±9.8岁),未服用降糖、降脂或负性变时性药物,接受了心肺运动试验,包括HRR-1测量和几个代谢参数的评估。将重度OSAS患者(呼吸暂停低通气指数[AHI]>30次/小时;n=32)与轻度至中度OSAS患者(AHI 5-30次/小时;n=31)进行比较。
重度OSAS患者男性比例更高(25例对3例;p=0.01),患高血压的比例更高(72%对39%;p=0.01);与轻度至中度OSAS患者相比,他们的空腹血糖水平也更高(5.4±0.5对5.1±0.4mmol/L;p=0.016),C肽水平更高[905(651-1353)对749(597-919)pmol/L;p=0.028]。两组在峰值心率(p=0.2)或峰值耗氧量(p=0.9)方面无差异,但重度OSAS患者的HRR-1显著低于轻度和中度OSAS患者[20(15-25)对24(18-34)次/分钟;p=0.022]。更高的AHI(p=0.01)和更低的峰值心率(p=0.02),而非体重指数或胰岛素抵抗,与更低的HRR-1独立相关。
以更高的AHI表示的OSAS严重程度与更低的HRR-1独立相关,HRR-1是自主神经功能障碍的一个指标。